Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;35(4):e15308.
doi: 10.1111/dth.15308. Epub 2022 Jan 17.

Squamous cell carcinoma: 2021 updated review of treatment

Affiliations
Review

Squamous cell carcinoma: 2021 updated review of treatment

Isabella Dreyfuss et al. Dermatol Ther. 2022 Apr.

Abstract

Squamous cell carcinoma is the second most common cutaneous malignancy, requiring early diagnosis to prevent metastasis. Updated guidelines in the definition of clinical features, diagnostic modalities, grading, staging, surgical, and nonsurgical treatment methods are necessary. Diagnostic methods from biopsy, dermoscopy, and reflectance confocal microscopy have improved to include high-frequency ultrasonography, optical coherence tomography, and computed tomography. Non-surgical treatment methods include topical therapy, cryosurgery, photodynamic therapy, and radiation. Surgical treatment methods include surgical excision with margins and Mohs surgery. Clinical trials encourage further research to address the knowledge base of genetic variations and lymph node metastasis.

Keywords: keratinocyte cancer; optical coherence tomography; phototherapy; reflectance focal microscopy; squamous cell carcinoma.

PubMed Disclaimer

References

REFERENCES

    1. Combalia A, Carrera C. Squamous cell carcinoma: an update on diagnosis and treatment. Dermatol Pract Concept. 2020;10(3):e2020066.
    1. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol. 2010;3(4):39-48.
    1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774-778.
    1. Day CL Jr, Mihm MC Jr, Lew RA, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg. 1982;195(1):35-43.
    1. Ibrahim SA, Kang BY, Poon E, Alam M. Guidelines of care for clinical laser treatments: why are they useful? J Cosmet Dermatol. 2021. doi:10.1111/jocd.14684

MeSH terms

LinkOut - more resources